Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cfptm1Song mutation
(0 available);
any
Cfp mutation
(3 available)
|
|
|
immune system
|
• LPS-induced alternative pathway (AP) complement activation is impaired unlike in wild-type mice
• however, zymosan-induced AP complement activation is normal
|
skeleton
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cfptm1Song mutation
(0 available);
any
Cfp mutation
(3 available)
Cr1ltm1Hmo mutation
(0 available);
any
Cr1l mutation
(30 available)
|
|
|
mortality/aging
N |
• mice are produced in Mendelian ratios unlike Cr1ltm1Hmo homozygotes that exhibit embryonic lethality
|
Allelic Composition |
Cfptm1Song/Y
|
|
Genetic Background |
involves: 129 * C57BL/6 |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cfptm1Song mutation
(0 available);
any
Cfp mutation
(3 available)
|
|
|
immune system
|
• sera of mice fail to initiate complement by activating C3 in response to LPS from three different bacteria species
• complement activity is restored when sera is pre-mixed with sera from C3tm1Hrc mice that lack the C3 enzyme
• there is a delayed activation of C3 in mouse sera when low amounts of CVF factor are added
|
|
• sera fail to initiate complement to LPS and to erthryocytes from mice that lack the complement inhibitor factor Crry (Cr1ltm1Hmo mice)
• complement induced by yeast wall zymogen is reduced by 1.6-fold
• systemic complement fails to initiate in mice one hour after injection of lipooligosaccharide
• systemic complement is reduced by about 2-fold one hour after injection of LPS
|
|
• antibody-mediated complement of sera is intact as measured by C3 activation in the presence of OVA and anti-OVA immunoglobulins
|